|
KPHMW Kiora Pharmaceuticals 1372514 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,079,010.00 |
| Balance Sheet |
|
Current Assets
|
$21,262,515.00 |
|
Assets
|
$23,776,090.00 |
|
Current Liabilities
|
$2,370,495.00 |
|
Liabilities
|
$6,919,401.00 |
|
Equity
|
$16,856,689.00 |
|
Shares Out
|
4427167.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,053,267.00 |
|
Investing Cash Flow
|
$-1,488,155.00 |
| Market Analysis |
Market Cap
|
$88,543.34 |
|
Price
|
$0.02 |
|
BVPS
|
3.81 |
|
PB
|
0.01 |
|
EPS
|
-0.34 |
|
FCF
|
$-5,081,741.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:17 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KPHMW documents filed with the SEC.
KPHMW Filings
Clear
